However, researchers and clinicians have observed its potential in a much broader population, especially in the context of: Visceral adiposity (deep belly fat) Growth hormone deficiency Cognitive aging Cardiometabolic risk reduction Its appeal lies in the ability to elevate IGF-1 (insulin-like growth factor-1) levels while preserving the bodys natural feedback mechanisms
Inhibition of fat production AOD 9604 inhibits adipogenesis through the following mechanisms: Inhibition of adipocyte differentiation: AOD 9604 can down-regulate the expression of peroxisome proliferator-activated receptor (PPAR) and CCAAT/ enhancer binding protein (C/EBP), and block the differentiation of preadipocytes into mature adipocytes
NNMT upregulation also elevates homocysteine levels, activating pro-inflammatory and pro-oxidative cascades (TLR4-NF-B and STAT3-IL-1 pathways) linked to atherosclerosis, heart failure, and coronary heart disease
A separate 2019 study in older mice reported that NNMT inhibition was associated with how muscle stem cells supported regeneration in rodent models a different research angle from the metabolic work
Switch to the ventrogluteal site for repeated dosing or clients with limited deltoid mass
Among the most talked-about weight-loss peptides are Semaglutide, AOD-9604, and Tesamorelin
